• 제목/요약/키워드: Human Toxicity Index

검색결과 42건 처리시간 0.036초

한국의 산업별 독성물질 배출과 인체유해도 측정 -산업연관분석의 응용- (Human Toxicity Index and Toxic Substances Emissions in Korea Industries)

  • 이해춘;김익;허탁
    • 자원ㆍ환경경제연구
    • /
    • 제15권4호
    • /
    • pp.643-672
    • /
    • 2006
  • 본 연구는 한국의 산업별 독성물질 배출량을 이용하여 산업별 인체유해도를 측정한 것이다. 분석에 이용된 자료는 146종의 인체유해화학물질 배출량과 2000년도 산업연관표이다. 분석결과, 총배출 강도가 높은 산업의 순위는 목재나무제품펄프종이(1.1632) >유기화학기초제품(0.9750) >기타화학제품(0.9620) >플라스틱제품(0.3804) >합성수지 및 합성고무(0.3412) >선박 및 기타 수송장비(0.3275) 등이다. 또한 인체발암지수는 산업 전체가 $11.86198{\times}10^3$(이미지참조)이며, 산업 평균이 $0.26360{\times}10^3$(이미지참조)으로 계산되었다. 인체유해도가 높은 산업의 순위를 보면, 자동차 및 부문품(7.85033) >선철 및 강반성품(4.57409) >철강 1차 제품(4.36668) >선박 및 기타 수송장비(3.43293) >무기화학기초제품(2.64379) 등이다. 총배출강도나 인체유해도 등은 인체유해 화학물질 감축을 위한 수요 및 산업 정책을 전개할 때, 규제산업의 우선순위를 결정하는 근거가 될 수 있다.

  • PDF

유전자 재조합 Human Factor VIII(GC-γ AHF)의 안전성에 관한 연구 (Safety Evaluation of Recombinant Human Factor VIII(GC-γ AHF))

  • 김민영;손장원;신민기;배미옥;김현우;최진혁;김준성;문서현;김정현
    • Toxicological Research
    • /
    • 제18권1호
    • /
    • pp.87-98
    • /
    • 2002
  • This study was conducted to evaluate the safety of a recombinant human Factor VIII(GC-$\gamma$ AHF) manufactured by Korea Green Cross Company with different technology according to the Regulation of Korean Food and Drug Administration (l 998. 12. 3). In acute toxicity test, both genders of Sprague-Dawley rats and Beagle dogs were administered intravenously with GC-$\gamma$ AHF of three doses (3,125, 625 and 125 IU/kg), and single dose of 3,125 IU/kg, respectively. No dead animal and abnormal autopsy findings were found in Control and GC-$\gamma$ AHF treated group. Therefore, the 50% lethal dose ($LD_{50}$) of GC-$\gamma$ AHF was conidered to be higher than 3,125 IU/kg in rats and dogs. In the four weeks repeated intravenous toxicity study, GC-$\gamma$ AHF was administrated intravenosly to both genders of rats and dogs with 3 doses (500, 150, 50 IU/kg). There were neither dead animals nor significant changes of body weights during the experimental Period. In addition, no significant GC-$\gamma$ AHF related changes were found in clinical sign, urinalysis and other finding. Statistically changes were observed in hematological, biochemical and organ weight parameters of treated groups: however these changes were not dose dependent. No histopathological lesion were observed in both control and treated animals. Above data suggest that no observed adverse effect level of test materials in rats and dogs might be over 500 IU/kg/day in this study. In ocular irritation test, any injury on iris, conjunctiva and cornea in rabbits were not observed. The acute ocular irritation index (A.O.I.), mean ocular irritation index (M.O.I.) and Day-7 individual ocular irritation Index (I.O.I.) of GC-$\gamma$ AHF were 0. In the primary skin Irritation test, the primary irritation index (P.I.I.) oj GC-$\gamma$ AHF were 0. Therefore, the GC-$\gamma$ AHF is considered not to have the primary skin and eye toxicity in rabbits. In active systemic anaphylaxis (ASA) test, GC-$\gamma$ AHF and GC-$\gamma$ AHF emulsified with Freund's complete adjuvant (FCA) did not induce any symptom of anaphylactic shock in guinea pigs. In passive cutaneous anaphylxis (PCA) test, after sensitization with antisera of GC-$\gamma$ AHF sensitized mice, blue spots were observed on the hypodermis of back of rats, but diameter of each spot was smaller than 5 mm in each test groups except the positive control group. Based on the results of this study, GC-$\gamma$ AHF is not conidered to have any antigenic potential. In conclusion, at levels of up to 500 IU/kg, GC-$\gamma$ AHF did not produce treatment-related toxicity under the conditions of these acute-, four week repeated-toxicity, primary skin and eye toxicity, and antigenicity test.

호기성 분해, 혐기성 분해 및 독성을 고려한 생분해도 지표 개발 (Biodegradability Index Development Based on Aerobic Biodegradation, Anaerobic Biodegradation, and Toxicity Test)

  • 유규선;신항식
    • 상하수도학회지
    • /
    • 제24권5호
    • /
    • pp.603-608
    • /
    • 2010
  • More than 8 millions of chemical have been used for human activities and lots of chemicals can not be degraded by microbial activities in this world. To show the biodegradability of a chemical, biodegradability index (B.I.) is suggested using aerobic biodegradability by $BOD_5$/COD, anaerobic biodegradability by methane potential (M.P.) and toxicity by the luminiscent bacteria. In this study, PVA (polyvinyl alcohol), HEC (hydroxy ethyl cellulose), 2,4,6-TCP (tri-chloro phenol) and 2,4-DCP (di-chloro phenol) are used for test chemicals. Though they show little toxicity, PAV and HEC have low B.I. because they are polymers having high molecular weight. That means that there are no bacteria that has enzyme to degrade polymer molecules. Also, anaerobic treatment is suggested better than aerobic treatment from B.I. 2,4,6-TCP and 2,4-DCP show high toxicity and have low B.I. Their low biodegradabilities seem to be originated from their toxicities. If B.I. is used in wastewater treatment, better treatment process can be suggested and finally it can lead our society to make more environment-friendly chemicals.

Risk Assessment of Dioxin in Japan

  • Kurokawa, Yuji
    • Toxicological Research
    • /
    • 제17권
    • /
    • pp.25-35
    • /
    • 2001
  • In 1990, Tolerable Daily Intake (TDI) of 10 pg TCDD/kg/day for dioxins based on carcinogenicity and reproductive toxicity was determined by WHO/EURO, that resulted in the establishment of TDIs in other countries. In Japan, Ministry of Health and Welfare and Environment Agency, respectively established the TDI of 10 pg TCDD/kg/day and Health Risk Assessment Index of 5 pg TCDD/kg/day in 1996. Accumulation of new scientific data, especially by molecular toxicology since 1990, resulted in the reevaluation of TDI by WHO-ECEH and IPCS in May, 1998. At this meeting, it was stressed that \circled1 toxic effects of dioxin is mediated through Ah-receptor in both animals and humans, \circled2 use of ebody burdeni concept is better than the use of traditional NOAEL/UF approach, \circled3 inclusion of coplanar PCBs in the TDI by the use of new WHO-TEF. LOAELs (0.16~200 ng TCDD/kg/day) obtained from reproductive toxicity and immunotoxicity in rats, and neurobehavioral toxicity and induction of endometriosis in rhesus monkeys are calculated to be the body burden of 10~50 ng TCDD/kg that is 14~37 pg TEQ/kg/day as human daily intake. Finally TDI of 1~4 pg TEQ/kg/day was established by applying the UF of 10. In Japan, reproductive toxicity and immunotoxicity in rats were used to obtain LOAELs (100~200 ng TCDD/kg/day). Finally TDI of 4 pg TEQ/kg/day was established in June 1999 by applying the UF of 10 to human daily intake of 43.6 pg TEQ/kg/day which corresponds to the body burden of 86 ng TCDD/kg.

  • PDF

ICR 마우스를 이용한 전호의 단회경구투여 독성 실험 (Single Dose Oral Toxicity Test of Peucedani Radix in ICR Mice)

  • 권다혜;김민영;황보현;지선영;박철;최영현;홍수현
    • 대한한방내과학회지
    • /
    • 제39권4호
    • /
    • pp.676-685
    • /
    • 2018
  • Objectives: The aim of this study was to estimate the single oral toxicity of Peucedani Radix (PR) ethanol extracts. PR is one of the important herbs for removal of phlegm, the viscous turbid pathological product that can accumulate in the body and cause a variety of diseases. However, research on the pharmacologic toxicity of PR is lacking. Methods: In this study, PR was orally administered to 5-week-old male ICR mice at an oral dose of 2,000, 3,000, or 5,000 mg/kg. After a single-dose administration, the mortality and behavioral changes were observed daily and body weights were measured every two days. After 14 days, the organ weight, organ index, macroscopy, hematological analysis, and serum biochemistry analysis were determined. Results: No mortality, body weight changes, abnormal behavioral changes, or anatomical signs of toxicity were found. The organ weight, organ index, hematological analysis, and serum biochemistry analysis were also within the normal ranges. Conclusions: These results suggest that the 50% lethal dose of PR is more than 5,000 mg/kg. This could indicate that PR is a safe drug without acute toxicity and side effects.

Biomolecular Mechanism of Cadmium Toxicity

  • Park, Jung-Duck
    • 대한약학회:학술대회논문집
    • /
    • 대한약학회 2002년도 Proceedings of the Convention of the Pharmaceutical Society of Korea Vol.2
    • /
    • pp.200-200
    • /
    • 2002
  • Cadmium (Cd) is an environmental pollutant and categorized as a human carcinogen, which has a tendency to accumulate in the human body. The level of Cd in renal cortex and liver are good indicators as an index of Cd exposure in general population. Geometric mean concentration of Cd is 27.4 and 3.1 /g wet weight in renal cortex and liver, respectively, in Korean. Cd is toxic to a number of tissues, notably the liver, kidney, testis, lung, lymphoid tissue and lung. (omitted)

  • PDF

연소 독성 기반 우레탄 화재의 위험성 평가 연구 (A Research of Risk Assessment for Urethane Fire Based on Fire Toxicity)

  • 김성수;조남욱;이동호
    • 한국화재소방학회논문지
    • /
    • 제29권2호
    • /
    • pp.73-78
    • /
    • 2015
  • 리스크 관리 대상 중 화재는 대형재해임과 동시에 물적 인적 손실을 동반하는 고위험군 항목에 속한다. 따라서 재난안전관리에서는 실천적 측면에서의 화재예방활동과 발생 가능한 화재위험성 예측, 화재 피해 최소화를 위한 안전관리비용 투자가 요구되며 인적피해 최소화를 위해 가스 유해성 시험(KS F 2271)기반 연소 독성에 대한 위험성 평가를 요구한다. 본 연구에서는 정량적 화재위험성평가 기법의 기초 데이터 확보를 위한 연구로, 두께 5~25 mm의 우레탄 시료를 대상으로 가스 유해성 시험을 실시하였다. 또한 실험동물에 노출되는 연소생성물은 적외선 분광분석기(FT-IR)로 분석하여 ISO 13344의 연소독성지수 Lethal Fractional Effective Dose ($L_{FED}$)를 산출하였다. 또한, $L_{FED}$에 기초하여 시료의 Lethal Concentration 50% ($LC_{50}$)을 산정한 결과, 일정치 이상의 화재하중을 가지는 우레탄 시료의 $LC_{50}$$118{\sim}129g/m^3$임을 확인하였다. 본 연구를 통하여 해당 기법이 우레탄 화재 위험성 분석에 적용 가능함을 확인하였으며, 본 기법의 적용으로부터 유해가스에 의한 인적피해 예측을 기반으로한 건축물 안전 확보 차원의 전략적 투자확대의 자료로 활용 가능케 하였다.

Development of human tumor necrosis factor-α muteins with improved therapeutic potential

  • Jang, Seung-Hwan;Kim, Hyo-Jin;Cho, Kwang-Hwi;Shin, Hang-Cheol
    • BMB Reports
    • /
    • 제42권5호
    • /
    • pp.260-264
    • /
    • 2009
  • Tumor necrosis factor-$\alpha$ (TNF-$\alpha$) exhibits cytotoxicity towards various tumor cells in vitro and induces apoptotic necrosis in transplanted tumors in vivo. It also shows severe toxicity when used systemically for the treatment of cancer patients, hampering the development of TNF-$\alpha$ as a potential anticancer drug. In order to understand the structure-function relation of TNF-$\alpha$ with respect to receptor binding, we selected four regions on the bottom of the TNF-$\alpha$ trimer that are in close contact with the receptor and carried out mutagenesis studies and computational modeling. From the study, various TNF-$\alpha$ muteins with a high therapeutic index were identified. These results will provide a structural basis for the design of highly potent TNF-$\alpha$ for therapeutic purposes. By conjugating TNF-$\alpha$ muteins with a high therapeutic index to a fusion partner, which targets a marker of angiogenesis, it could be possible to develop TNF-$\alpha$ based anticancer drugs.

우리나라 농민의 Chlorpyrifos에 대한 피부 위해성 평가 (Human Dermal Risk Assessment on Chlorpyrifos of Korean Farmers)

  • 정경미;이효민;이은희;이선희;김진화;심영용;홍진태;이용욱
    • 한국환경성돌연변이발암원학회지
    • /
    • 제22권3호
    • /
    • pp.187-198
    • /
    • 2002
  • Chlorpyrifos is an organophosphate insecticide and one of the most commonly and widely used insecticide. However, a little known about the dermal risk of chlorpyrifos on human being. Therefore, this study was conducted for the dermal risk assessment after exposure to chlorpyrifos in Korean farmers. First, skin irritation by chlorpyrifos (10 mg/$\textrm{cm}^2$, 50 mg/$\textrm{cm}^2$, 100 mg/$\textrm{cm}^2$, 250 mg/$\textrm{cm}^2$ in acetone) was determined in rabbits for 5 days considering the usage of chlorpyrifos short term highly exposure. The index of skin irritation by chlorpyrifos was increased in each dose and length of exposure dependent manners. Next, using benchmark dose (BMD$_{5}$) approach, the dose-response relationship was assessed to calculate the reference dose (RfD). The value of RfD was 2.84 $\mu\textrm{g}$/kg/day from 142.16 $\mu\textrm{g}$/kg/day BMD5 value divided uncertainty factor 50. Finally, we assessed human dermal risk of chlorpyrifos with exposure level and RfD. Skin absorbed levels were assumed with several exposure scenarios encounting the circumstances of exposure that application method, protection equipment and cloth, exposure time and exposure frequency during chlorpyrifos spraying. By the comparison of skin absorbed dose with the reference dose, it was identified that risk values (risk index) to skin chlorpyrifos exposure were 0.958 from the point of above results and it was recommended that the occurrence of hazard effect (skin irritation toxicity) of chlorpyrifos would not be expected. Risk index was smaller than 1 in the case of spraying vehicle mounted application, 1hour exposure time and wearing protective cloth exposure. Whereas, risk index was above 1 in the case of hand-held application, 2hour exposure time and wearing common cloth. Comparing two kinds of application method, total risk index of the hand held application (1.67) was higher than vehicle mounted (0.27). Therefore, chlorpyrifos skin exposure was mainly affected by application equipment and applied form. The results of risk assessment on the human dermal toxicity of chlorpyrifos should be required to control in keeping safety rules, skin surface area available for contact, spraying time ,and spraying frequency.y.

  • PDF

형질전환 비만모델 수컷 hGHTg rats에서 경신해지환(輕身解脂丸)이 혈중 항비만지표에 미치는 영향 (The effects GeongshinhaeGihwan 1(GGT1) has on the hGHTg (human growth hormone transgenic) obese male rats' blood-antiobestic index)

  • 정양삼;총배금;최승배;김경철;신순식
    • 대한한의학방제학회지
    • /
    • 제13권2호
    • /
    • pp.1-16
    • /
    • 2005
  • Objectives: To find out the effects GGTl, an antiobestic drug widely used in clinics, has on the blood-antiobestic index and the toxicity index using the data from the hGHTg obese male rats. We looked closely into both of the two indices because GGTl antiobestic effect can happen not only by pharmacological action, but also by its toxicity. Also, we verified the difference in effect between GGTl and reductil (sibutramine), which has been approved by the FDA of the United States. Methods: After performing the experiments for 8 weeks on the hGHTg obese male rats divided into three groups: the control group, the GGTl group, and the reductil (RD) group, we anesthetized the rats with Diethyl ether and took a 3ml blood sample from the heart. Then, after coagulating the blood in room temperature by using the plasma separator, we centrifuged it for 25 minutes in 3,000rpm using the high-speed refrigerated centrifuge. We kept the separated plasma in a deep freezer at $-80^{\circ}C$, and repeatedly measured the antiobestic index and the toxicity index twice using the hematology biochemistry analyzer. Also, in order to judge the indirect toxicity index, we separated liver from kidney and observed them. Results: When we looked at the results of the analysis of covariance on the measuring elements related to the antiobestic index (TC, HDL, LDL, TG, and GLU), there was no significant difference among the groups in all measuring elements. Also, the results of the analysis of covariance on the two roups (RD group and GGTl group) showed that the p-values had no significant difference under the level of significance 0.05. When we looked at the result of the analysis of covariance on the measuring elements related to the toxicity index (GOT, GPT, GGT, CREA, UA, ALB, and TP), we could see that the p-values in GPT, ALB, and TP have a significant difference among the groups. Also, the results of the analysis of covariance about the measuring elements related to the toxicity index on both groups, RD group and GGTl group, showed no significant difference in the p-values of all of the measuring elements in the two groups, RD and GGTl group. Conclusions: In conclusion, through this experiment, the safety of GGTl has been approved, and although the verification on its medical effect has not been clearly approved, when we consider the fact that it belongs to the same group as reductil, an antiobestic drug approved by the FDA of the United States, we could indirectly verify that GGTl has an antiobestic effect. We believe that when doing a sample design for a future experiment, it needs to be performed on a greater sample size based on the power analysis that needs to be performed primarily in experiments, and a more accurate verification is needed through more systematic experiment plans.

  • PDF